The stock of AdaptHealth Corp. (NASDAQ:AHCO) decreased by -$0.04 on Friday to finish at $11.61, down -0.34 percent. The last five days have seen an average of 1,034,620 shares of common stock traded. 9 times new highs were reached in the current year, with a fall of -$7.61. The average number of shares traded over the last 20 days was 1,533,385, while the average volume over the last 50 days totaled 1,377,596.
AHCO stock dropped -12.64% since last month. On 08/17/23, the company’s shares reached a one-month low of $10.86. The stock touched a high of $23.30 on 02/23/23, after rallying from a low of $9.32 in 52 weeks. The price of AHCO stock has declined by -39.59% or -$7.61 this year, reaching a new high 9 times. Still, the stock price is down -50.17% from the 52-week high.
Insider Transactions
AHCO stock investors should be aware that AdaptHealth Corp. (AHCO) stock had its last reported insider trading activity 17 days ago on Aug 11. On Aug 11, Director SkyKnight Aero Holdings, LLC sold 137,787 shares at $14.02 each. This transaction resulted in the insider making $1,931,085. On Aug 11, SkyKnight Aero Holdings, LLC sold 59,052 shares at a price of US$14.02. After the transaction, the insider now owns 5,565,126 shares. Chief Financial Officer Clemens Jason A had earlier bought 720 shares on Aug 10 for $14.10 a share. The transaction was completed for $10,152.
Valuation Metrics
AdaptHealth Corp. (AHCO) has a trailing price-to-earnings (P/E) ratio of 40.17. Beta for the stock is 0.73. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 0.52, the price-to-book (PB) ratio of 0.71, and the price-to-cash flow ratio of 73.07.
Financial Health
For the three months ended June 29, AdaptHealth Corp.’s quick ratio was 1.00, while its current ratio was 1.20, indicating its ability to pay off its debt. The company’s long-term debt to equity ratio for the quarter ending June 29 is 0.98, and the total debt to equity ratio is 1.00. As far as profitability goes, gross margin for the trailing twelve months is 15.20% percent. AdaptHealth Corp.’s EBITDA margin for the year ended June 29 was 20.87%, whereas its operating margin stood at 4.80% for the same period. Based on annual data, it had gross profit of $417.43 million and revenue of $2.97 billion.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. AHCO’s return on assets (ROA) during the last 12 months has been 0.80%. There was a 3.60% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was 1.80%.
Earnings Surprise
According to AdaptHealth Corp.’s quarterly financial report for the quarter that ended June 29. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $793.29 million, while revenues rose by 8.28% to $744.63 million. It was predicted that AdaptHealth Corp.’s quarterly earnings would be $0.09, but it ended up being $0.1. EBITDA was $154.87 million for the quarter. At the end of AdaptHealth Corp.’s most recent quarter ended June 29, its liabilities totaled 3.02 billion, while its total debt was $2.31 billion. Equity owned by shareholders amounts to $136.11 million.
Technical Picture
Here’s a quick look at AdaptHealth Corp.’s (AHCO) price momentum from a technical perspective. As of 25 August, the RSI 9-day stood at 32.13%, suggesting the stock is Neutral, with a 75.27% historical volatility rate.
The stochastic %K and %D were 19.73% and 19.83% respectively, while the average true range (ATR) was 0.62. Based on the 14-day stochastic reading of 16.63%, the RSI (14) reading is 37.03%. On the 9-day MACD Oscillator, the stock is at -0.30, and the 14-day reading is at -1.08.
Analyst Ratings
AdaptHealth Corp. (NASDAQ: AHCO) was downgraded by Stifel to a a Hold rating in its latest research report. The stock was previously rated as a a Buy. Analysts have assigned AdaptHealth Corp. (AHCO) an Overweight rating. AHCO is a stock that is recommended for selling by 0 brokerage firms, while 3 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 1 rate it overweight and 6 others recommend it as a buy.
What is AHCO’s price target for the next 12 months?
The current consensus forecast for the stock is between $14.00 and $21.00, with a median target price of $17.50. In analyzing these forecasts, the average price target given by analysts for AdaptHealth Corp. (AHCO) is $17.30.
